BLOG: This week we’re actively campaigning in Wales to improve treatment and support for local men.
BLOG: In his latest exclusive blog for Prostate Cancer UK, Jeff Stelling looks forward to being reunited with the extraordinary Kevin Webber, meeting the Green family on the pitch at Exeter City, and pottering with former-England cricketer Dominic Cork in the Potteries.
BLOG: It's been 12 months since we launched our ambitious plan to halve prostate cancer deaths in a decade, and we’ve already taken some huge steps towards our goal. Our chief executive, Angela Culhane, reflects on the progress we’ve made and the exciting work still to come.
BLOG: Today, Prostate Cancer UK and 67 other charities signed a joint letter to the Prime Minister, urging the government to use the Spring Budget to give the NHS the money it needs to end the current crisis. Our Change Delivery Manager, Martin Abrams, explains why the NHS's whole future is at stake.
BLOG: Today's announcement about mpMRI scans before a biopsy is a game-changer for prostate cancer diagnosis. But without Prostate Cancer UK's funding of a pilot project in 2010 thanks to your donations, this ground-breaking research would never have happened, says Dr Ian Le Guillou.
BLOG: We're only 12 months into our ten-year strategy to tame prostate cancer, but that doesn't mean we haven't already made exciting progress. Our resident expert, Dr Ian Le Guillou, gives us his top ten biggest research breakthroughs (in no particular order) from 2016.
BLOG: After Prostate Cancer UK bombarded the health authority with substantial evidence and demanded changes, NICE announced they will now undertake an exceptional review of their prostate cancer clinical guidelines. Our CEO, Angela Culhane, explains why it will mean life-saving new diagnosis and treatment should reach thousands of men sooner than expected.
BLOG: While doom-laden reports about chronic underfunding appear daily in the news, the NHS is still committed to transforming cancer treatment in the UK by 2020. So is it all just pie in the sky? Our Policy Manager, Phillip Anderson, doesn't think so, but argues we must get smarter about making our case for investment in prostate cancer if we're going to get the best deal for men.
BLOG: A win-win situation is possible for both a cash-strapped NHS and expensive pharmaceutical companies, argues our chief executive, Angela Culhane, who recently addressed an influential forum of health experts at Westminster. The key is to transform earlier detection and treatment of prostate cancer before more expensive drugs even become necessary.
BLOG: With over 60 applicants from scientists all over the UK for our first ever Research Innovation Awards, Deputy Director of Research Dr Matthew Hobbs explains the pressures and difficulties of deciding which projects to give the £2.6million of funding and why he hopes to do even better next year.